Karine Barral

1.6k total citations
24 papers, 1.2k citations indexed

About

Karine Barral is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Karine Barral has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Infectious Diseases and 7 papers in Virology. Recurrent topics in Karine Barral's work include HIV/AIDS drug development and treatment (12 papers), Biochemical and Molecular Research (9 papers) and HIV Research and Treatment (7 papers). Karine Barral is often cited by papers focused on HIV/AIDS drug development and treatment (12 papers), Biochemical and Molecular Research (9 papers) and HIV Research and Treatment (7 papers). Karine Barral collaborates with scholars based in France, Belgium and United Kingdom. Karine Barral's co-authors include Adam D. Moorhouse, John E. Moses, Bruno Coutard, Étienne Decroly, Xavier de Lamballerie, Jacques van Helden, Franck Touret, Bruno Canard, Antoine Nougaırède and Magali Gilles and has published in prestigious journals such as Journal of Virology, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Karine Barral

24 papers receiving 1.2k citations

Peers

Countries citing papers authored by Karine Barral

Since Specialization

Citations

This map shows the geographic impact of Karine Barral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karine Barral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karine Barral more than expected).

Fields of papers citing papers by Karine Barral

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karine Barral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karine Barral. The network helps show where Karine Barral may publish in the future.

Co-authorship network of co-authors of Karine Barral

This figure shows the co-authorship network connecting the top 25 collaborators of Karine Barral. A scholar is included among the top collaborators of Karine Barral based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karine Barral. Karine Barral is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	2C protein of Enterovirus: key protein of viral replication and antiviral target	Virologie	Ziad Fajloun, Patrice Vanelle et al.	3
2	Discovery of a PDZ Domain Inhibitor Targeting the Syndecan/Syntenin Protein–Protein Interaction: A Semi-Automated “Hit Identification-to-Optimization” Approach	Journal of Medicinal Chemistry	Laurent Hoffer, Raphaël Leblanc et al.	4
3	Fragment-based drug design targeting syntenin PDZ2 domain involved in exosomal release and tumour spread	European Journal of Medicinal Chemistry	Laurent Hoffer, Raphaël Leblanc et al.	9
4	In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication	Scientific Reports	Franck Touret, Magali Gilles et al.	261
5	Optimization of a fragment linking hit toward Dengue and Zika virus NS5 methyltransferases inhibitors	European Journal of Medicinal Chemistry	Jessica Hernández-Rodríguez, Laurent Hoffer et al.	20
6	Discovery of novel dengue virus NS5 methyltransferase non-nucleoside inhibitors by fragment-based drug design	European Journal of Medicinal Chemistry	Bruno Coutard, Étienne Decroly et al.	70
7	Novel 2-phenyl-5-[(E)-2-(thiophen-2-yl)ethenyl]-1,3,4-oxadiazole and 3-phenyl-5-[(E)-2-(thiophen-2-yl)ethenyl]-1,2,4-oxadiazole derivatives as dengue virus inhibitors targeting NS5 polymerase	European Journal of Medicinal Chemistry	Cécilia Eydoux, Gilles Quérat et al.	60
8	Assessment of Dengue virus helicase and methyltransferase as targets for fragment-based drug discovery	Antiviral Research	Bruno Coutard, Étienne Decroly et al.	51
9	Development of specific dengue virus 2′-O- and N7-methyltransferase assays for antiviral drug screening	Antiviral Research	Karine Barral, Bruno Coutard et al.	36
10	Acyclic nucleoside thiophosphonates as potent inhibitors of HIV and HBV replication	European Journal of Medicinal Chemistry	Karine Barral, Loïc Roux et al.	7
11	Synthesis and antiviral activity of boranophosphonate isosteres of AZT and d4T monophosphates	European Journal of Medicinal Chemistry	Karine Barral, Stéphane Priet et al.	8
12	Acyclic Phosphonate Nucleotides and Human Adenylate Kinases: Impact of a Borano Group on α-P Position	Nucleosides Nucleotides & Nucleic Acids	Dimitri Topalis, Karine Alvarez et al.	12
13	Gln151 of HIV-1 Reverse Transcriptase Acts as a Steric Gate Towards Clinically Relevant Acyclic Phosphonate Nucleotide Analogues	Antiviral Therapy	Cécile Bussetta, Jérôme Deval et al.	10
14	In Vitro Suppression of K65R Reverse Transcriptase-Mediated Tenofovir- and Adefovir-5′-Diphosphate Resistance Conferred by the Boranophosphonate Derivatives	Antimicrobial Agents and Chemotherapy	Karine Barral, Karine Alvarez et al.	10
15	Efficient Conversion of Aromatic Amines into Azides: A One-Pot Synthesis of Triazole Linkages	Organic Letters	Karine Barral, Adam D. Moorhouse et al.	346
16	Synthesis, in Vitro Antiviral Evaluation, and Stability Studies of Novel α-Borano-Nucleotide Analogues of 9-[2-(Phosphonomethoxy)ethyl]adenine and (R)-9-[2-(Phosphonomethoxy)propyl]adenine	Journal of Medicinal Chemistry	Karine Barral, Stéphane Priet et al.	39
17	Synthesis and Antiviral Evaluation of Cyclic and Acyclic 2-Methyl-3-hydroxy-4-pyridinone Nucleoside Derivatives	Journal of Medicinal Chemistry	Karine Barral, Jan Balzarini et al.	20
18	Synthesis and Antiviral Evaluation of Cis-Substituted Cyclohexenyl and Cyclohexanyl Nucleosides	Journal of Medicinal Chemistry	Karine Barral, Jérôme Courcambeck et al.	31
19	Synthesis and antiviral evaluation of 3-hydroxy-2-methylpyridin-4-one dideoxynucleoside derivatives	Bioorganic & Medicinal Chemistry Letters	Karine Barral, Robert C. Hider et al.	8
20	Synthesis of (±) cis-substituted cyclohexenyl and cyclohexanyl nucleosides via a double Mitsunobu-type reaction	Tetrahedron Letters	Karine Barral, Philippe Halfon et al.	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact